Humana Inc (HUM) stock

HUMNYSEHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3051% above fair value

$450.00+6.32 (+1.42%)

Close on Nov 13, 2026Market cap $54.04BP/E 43.6Yield 0.79%

Humana price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Humana's price to sales ratio was 0.4× on Nov 11, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.2× to 0.8×, with a median of 0.4×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	0.4×	+0.1
2025	Dec 31, 2025	0.2×	−0.0
2024	Dec 31, 2024	0.3×	−0.3
2023	Dec 29, 2023	0.6×	−0.2
2022	Dec 30, 2022	0.7×	−0.0
2021	Dec 31, 2021	0.7×	+0.0
2020	Dec 31, 2020	0.7×	−0.1
2019	Dec 31, 2019	0.8×	+0.1
2018	Dec 31, 2018	0.7×	+0.0
2017	Dec 29, 2017	0.7×	+0.1
2016	Dec 30, 2016	0.6×	+0.1
2015	Dec 31, 2015	0.5×	+0.0
2014	Dec 31, 2014	0.5×	+0.1
2013	Dec 31, 2013	0.4×	+0.1
2012	Dec 31, 2012	0.3×	−0.1
2011	Dec 30, 2011	0.4×	+0.1
2010	Dec 31, 2010	0.3×	–